EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;33:712-716. doi:10.1016/j.ejcts.2008.01.025
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hong Kwan Kim
Yong Soo Choi
Kwhanmien Kim
Young Mog Shim
Kiick Sung
Young Tak Lee
Pyo Won Park
Jhingook Kim
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Kim, H. K.
Right arrow Articles by Kim, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, H. K.
Right arrow Articles by Kim, J.
Related Collections
Right arrow Lung - other
Right arrow Great vessels

Surgical treatment for pulmonary artery sarcoma

Hong Kwan Kim, Yong Soo Choi, Kwhanmien Kim, Young Mog Shim, Kiick Sung, Young Tak Lee, Pyo Won Park, Jhingook Kim*

Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Received 1 October 2007; received in revised form 20 December 2007; accepted 16 January 2008.

* Corresponding author. Address: Department of Thoracic Surgery, Samsung Medical Center, 50 Ilwon-dong, Gangnam-gu, Seoul 135-710, South Korea. Tel.: +82 2 3410 3483; fax: +82 2 3410 0089. (Email: jkimsmc{at}skku.edu).

Objective: Pulmonary artery sarcomas are exceedingly rare and the prognosis for patients with pulmonary artery sarcoma is very poor. We retrospectively reviewed the early and late outcomes after treatment for pulmonary artery sarcoma, and the purpose of this study is to report our surgical experience with this fatal disease. Methods: Between 1999 and 2007, a total of nine patients (mean age, 47.4 years; M:F = 4:5) underwent operations for pulmonary artery sarcoma at our institution. The tumor was radically resected and every effort was made to remove the tumor as completely as possible. Seven patients underwent surgical resection with the aid of hypothermic cardiopulmonary bypass. The completeness of resection was determined intraoperatively by frozen section biopsy of the resection margin. Results: There was no in-hospital mortality. No patients suffered from significant complications related to the operation. Follow-up was completed for all the patients with a mean duration of 19.2 months. During follow-up, six patients died with a median survival time of 17.6 months. The cause of death was related to the recurrence of pulmonary artery sarcoma in all cases. The pattern of recurrence was local recurrence and distant metastasis in three and four patients, respectively. Conclusions: The early outcomes after surgical treatment for pulmonary artery sarcoma were excellent, and the late outcomes in this series were no worse than those in the previous reports. We suggest that the use of cardiopulmonary bypass is important to obtain a complete resection and the completeness of the resection should be confirmed intraoperatively by frozen section biopsy of the resection margin.

Key Words: Pulmonary arteries • Sarcoma • Cardiopulmonary bypass







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.